Human resources requirements for highly active antiretroviral therapy scale-up in Malawi

Muula, Adamson S.; Chipeta, John; Siziya, Seter; Rudatsikira, Emmanuel; Mataya, Ronald H.; Kataika, Edward
January 2007
BMC Health Services Research;2007, Vol. 7, p208
Academic Journal
Background: Twelve percent of the adult population in Malawi is estimated to be HIV infected. About 15% to 20% of these are in need of life saving antiretroviral therapy. The country has a public sector-led antiretroviral treatment program both in the private and public health sectors. Estimation of the clinical human resources needs is required to inform the planning and distribution of health professionals. Methods: We obtained data on the total number of patients on highly active antiretroviral treatment program from the Malawi National AIDS Commission and Ministry of Health, HIV Unit, and the number of registered health professionals from the relevant regulatory bodies. We also estimated number of health professionals required to deliver highly active antiretroviral therapy (HAART) using estimates of human resources from the literature. We also obtained data from the Ministry of Health on the actual number of nurses, clinical officers and medical doctors providing services in HAART clinics. We then made comparisons between the human resources situation on the ground and the theoretical estimates based on explicit assumptions. Results: There were 610 clinicians (396 clinical officers and 214 physicians), 44 pharmacists and 98 pharmacy technicians and 7264 nurses registered in Malawi. At the end of March 2007 there were 85 clinical officer and physician full-time equivalents (FTEs) and 91 nurse FTEs providing HAART to 95,674 patients. The human resources used for the delivery of HAART comprised 13.9% of all clinical officers and physicians and 1.1% of all nurses. Using the estimated numbers of health professionals from the literature required 15.7-31.4% of all physicians and clinical officers, 66.5-199.3% of all pharmacists and pharmacy technicians and 2.6 to 9.2% of all the available nurses. To provide HAART to all the 170,000 HIV infected persons estimated as clinically eligible would require 4.7% to 16.4% of the total number of nurses, 118.1% to 354.2% of all the available pharmacists and pharmacy technicians and 27.9% to 55.7% of all clinical officers and physicians. The actual number of health professionals working in the delivery of HAART in the clinics represented 44% to 88.8% (for clinical officers and medical doctors) and 13.6% and 47.6% (for nurses), of what would have been needed based on the literature estimation. Conclusion: HAART provision is a labour intensive exercise. Although these data are insufficient to determine whether HAART scale-up has resulted in the weakening or strengthening of the health systems in Malawi, the human resources requirements for HAART scale-up are significant. Malawi is using far less human resources than would be estimated based on the literature from other settings. The impact of HAART scale-up on the overall delivery of health services should be assessed.


Related Articles

  • Healthcare utilization of patients accessing an African national treatment program. Harling, Guy; Orrell, Catherine; Wood, Robin // BMC Health Services Research;2007, Vol. 7, p80 

    Background: The roll-out of antiretroviral therapy (ART) in Africa will have significant resource implications arising from its impact on demand for healthcare services. Existing studies of healthcare utilization on HAART have been conducted in the developed world, where HAART is commenced when...

  • Physical and emotional health outcomes after 12 months of public-sector antiretroviral treatment in the Free State Province of South Africa: a longitudinal study using structural equation modelling. Wouters, Edwin; Heunis, Christo; van Rensburg, Dingie; Meulemans, Herman // BMC Public Health;2009, Vol. 9 Issue 1, p1 

    Background: African and Asian cohort studies have demonstrated the clinical efficacy of antiretroviral treatment (ART) in resource-limited settings. However, reports of the long-term changes in the physical and emotional quality of life (QoL) of patients on ART in these settings are still...

  • highly active antiretroviral therapy (HAART):. Huber, Jeffrey T.; Gillaspy, Mary L. // Encyclopedic Dictionary of AIDS-Related Terminology;2000, p108 

    An encyclopedia entry for "highly active antiretroviral therapy" is presented. This therapy refers to a powerful combination of drugs, which renders human immunodeficiency viruses undetectable in the body of an infected person. This therapy contains one drug that is usually an HIV protease...

  • Access to highly active antiretroviral therapy (HAART) in the WHO European Region 2003—2005. Bollerup, Annemarie R.; Donoghue, Martin C.; Lazarus, Jeffrey V.; Nielsen, Stine; Matic, Srdan // Scandinavian Journal of Public Health;Mar2008, Vol. 36 Issue 2, p8 

    Aims: To assess changes in access to highly active antiretroviral therapy (HAART) between the end of 2002 and the end of 2005, and to review the capacity for further HAART scale-up in the then 52 Member States of the WHO European Region. Methods: Analysis of data from four surveys evaluating...

  • Effect of Free Treatment and Surveillance on HIV-Infected Persons Who Have Tuberculosis, Taiwan, 1993-2006. Shu-Hui Tseng; Dah-Shyong Jiang, Donald; Hao-Seong Hoi; Hsiu-Yun Lo; Kao-Pin Hwang // Emerging Infectious Diseases;Feb2009, Vol. 15 Issue 2, p332 

    In 1997, Taiwan made highly active antiretroviral therapy (HAART) available without cost to HIV-infected persons; in 2001, a national web-based surveillance system was implemented. Healthcare workers use the system to monitor patients' conditions and can intervene when necessary. Free HAART,...

  • Modelling response to HIV therapy without a genotype: an argument for viral load monitoring in resource-limited settings. Revell, A. D.; Wang, D.; Harrigan, R.; Hamers, R. L.; Wensing, A. M. J.; DeWolf, F.; Nelson, M.; Geretti, A.-M.; Larder, B. A. // Journal of Antimicrobial Chemotherapy (JAC);Apr2010, Vol. 65 Issue 4, p605 

    In the absence of widespread access to individualized laboratory monitoring, which forms an integral part of HIV patient management in resource-rich settings, the roll-out of highly active antiretroviral therapy (HAART) in resource-limited settings has adopted a public health approach based on...

  • Population uptake of antiretroviral treatment through primary care in rural South Africa. Cooke, Graham S.; Tanser, Frank C.; Bärnighausen, Till W.; Newell, Marie-Louise // BMC Public Health;2010, Vol. 10 Issue 1, p585 

    Background: KwaZulu-Natal is the South African province worst affected by HIV and the focus of early modeling studies investigating strategies of antiretroviral treatment (ART) delivery. The reality of antiretroviral roll-out through primary care has differed from that anticipated and real world...

  • Review of antiretroviral agents for the treatment of HIV infection. Stanic, Anela; Grana, Julie C. // Formulary;Feb2009, Vol. 44 Issue 2, p47 

    Research into the treatment of HIV infection has resulted in the development of 5 antiretroviral (ARV) drug classes: entry inhibitors, including fusion inhibitors and chemokine coreceptor (CCR) inhibitors; nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs); non-nucleoside reverse...

  • Clinical Management of Treatment- Experienced, HIV/AIDS Patients in the Combination Antiretroviral Therapy Era. Boyd, Mark A.; Hill, Andrew M. // PharmacoEconomics;2010 Supplement, Vol. 28, p17 

    Despite the success of combination antiretroviral therapy (ART) in improving clinical outcomes, treatment failure remains a significant challenge, particularly for highly treatment-experienced patients. This review evaluates current issues in the management of HIV-infected, treatment-experienced...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics